10 results about "Sacral nerve" patented technology

Botulinum toxin for use in treating asthma in a patient in need thereof is provided. The treatment comprises administering botulinum toxin to the patient. The botulinum toxin may be administered by subcutaneous or intradermal injection. The subcutaneous or intradermal injection may be administered to and / or around the vicinity of a trigeminal nerve, a cervical nerve, a thoracic nerve, a lumbar nerve, a sacral nerve, or a combination thereof of the patient.

The present application relates to the technical field of nerve monitoring, in particular to an intraoperative real-time feedback system and method for sacral nerve stimulation, the system comprising: a biological motion sensing unit for real-time monitoring of the body surface contraction movement of the perineum and perianal area and foot movement through a sensor and generating corresponding multi-modal sensing signals; a processing unit for receiving the multi-modal sensing signals and performing synchronization and feature extraction, inputting the extracted features into a pre-trained machine learning model to obtain a judgment result representing the effect of sacral nerve electrode implantation target point and the accuracy of the target point position; a feedback unit for receiving the judgment result and converting it into feedback information for unified display. The present application realizes objective quantitative evaluation through multi-modal signal synchronous perception and fusion, as well as integrated machine learning model, provides intelligent and predictive feedback beyond simple threshold judgment, and realizes precise guidance of electrode implantation.

The present invention relates to a medical device, and in particular to, a urinary catheter capable of preventing and treating lower urinary tract symptoms by means of electrical stimulation. The technical problem to be solved by the present invention is that the existing urinary catheter can stimulate the bladder mucosa to cause bladder spasm, and the existing urinary catheter only has the function of urine drainage, and does not have the function of preventing and treating lower urinary tract symptoms such as bladder spasm at the same time; the existing electrical nerve stimulation device aims at other nerves such as the nervi sacrales and needs to be surgically implanted; and the existing bladder electrotherapy device does not have the function of the urinary catheter. The present invention provides a urinary tube for treating lower urinary tract symptoms and lower urinary tract dysfunction by means of electrical stimulation. An electrode is arranged at a set position on the urinary tube, the electrode is connected to a discharge device, and electrical pulses are directly applied to parts such as the bladder wall, so as to achieve the purposes of alleviating lower urinary tract symptoms and treating lower urinary tract dysfunction. The present invention is a brand-new medical device. The present invention is characterized in that the electrode is arranged at one or more positions of the urinary tube in contact with the urinary tract, and the electrode reaches the tail section of the tube by means of a wire and is connected to the discharge device. According to the position and number of the electrode on the urinary tube, an electrode circuit, and parameters of the discharge device, multiple electrical stimulation modes can be achieved by means of combination and match, such that the urinary tube can produce multiple different electrotherapy effects.

The invention discloses sacral nerve electrical stimulation equipment and a use method thereof, and relates to the technical field of nerve treatment.The sacral nerve electrical stimulation equipment comprises a pulse generator, a connector is fixedly connected to the top of the pulse generator, a wire is installed in the connector, a catheter sleeves the outer side of the wire, a plurality of electrodes are arranged on the outer side of the tail end of the wire, and the electrodes are electrically connected with the pulse generator. The sacral nerve electrical stimulation device comprises a pulse generator, a connector and a wire, a main patch is placed on the surface of the pulse generator, a through hole is formed in the surface of the main patch, a mounting cabin is fixedly connected to the surface of the pulse generator, and one end of the mounting cabin extends to the outer side of the through hole. The electrode can be implanted into the body of a patient, meanwhile, when not in use, the electrode and the wire can be pulled out of the body of the patient, the electrode and the wire do not need to be embedded into the body of the patient, and the device can be pulled out during short-term treatment and poor treatment effect.

A method of treating vertigo in a patient in need thereof comprises administering a botulinum toxin to the patient. The botulinum toxin may be administered by subcutaneous / intradermal injection. The subcutaneous / intradermal injection may be administered to and / or around the vicinity of a trigeminal nerve, a cervical nerve, a thoracic nerve, a lumbar nerve, and a sacral nerve of the patient.

A wearable system with urine storage and urination stimulation functions comprises a waist fixing structure, a body surface sacral nerve electrical stimulation structure, a bladder peripheral nerve stimulation structure and a control structure. The body surface sacral nerve electrical stimulation structure and the bladder peripheral nerve stimulation structure are fixed on the waist fixing structure; the bladder peripheral nerve structure comprises a percussion stimulation structure fixed to the waist fixing structure and a bladder peripheral nerve electrical stimulation structure fixed to an inner side plate of a shell of the percussion stimulation structure. The percussion structure of the percussion stimulation structure is arranged in the shell in a retracted state in an unused state. The control structure controls the electrical stimulation structure to be in a urine storage mode when the electrical stimulation frequency is 5-10 Hz and to be in a urination mode when the electrical stimulation frequency range is 10-20 Hz; the percussion of the percussion stimulation structure is in a urination mode; the control structure controls the rehabilitation mode when the electrical stimulation frequency range is smaller than 5 Hz. Certainly, a lateral electrical stimulation structure can be included for auxiliary stimulation. The system can effectively set a plurality of modes to meet the use requirements of different patients.

Systems and methods for implanting sacral nerve stimulation leads through a target sacral foramen and proximate a target sacral nerve are disclosed. For example, an alignment system including a primary alignment feature and a secondary alignment feature couplable to the primary alignment feature are provided. The primary alignment feature lies flat against the patient's skin and includes radiopaque grid lines that form a coordinate system on the patient's skin. An imaging device obtains a first image that includes both the primary alignment feature and the target foramen. The position of the target foramen is correlated to a position on the primary alignment feature based on the first image. The secondary alignment feature is coupled to the primary alignment feature and provides an indication of the specific insertion point and insertion angle for a delivery instrument carrying a signal delivery device into the patient.

The embodiment of the utility model provides a sacral nerve stimulation electrode assembly and a guiding device. The sacral nerve stimulation electrode assembly comprises a stimulation electrode, a first limiting assembly and a second limiting assembly. Wherein the stimulating electrode is used for stimulating sacral nerves; the first limiting assembly is arranged on the stimulating electrode and located at the end, close to the target point, of the stimulating electrode. The second limiting assembly is arranged on the stimulating electrode, the first limiting assembly is located at the end, close to a target spot, of the stimulating electrode, and the second limiting assembly and the first limiting assembly are arranged oppositely or oppositely; the first limiting assembly and the second limiting assembly are used for limiting the stimulating electrode to move in the axial direction, and therefore the problem that the stimulating electrode is prone to displacement in subcutaneous tissue, and consequently the sacral nerve stimulating effect is poor is solved. The sacral nerve stimulation electrode assembly guiding device prevents the first limiting assembly and the second limiting assembly from structural deformation in the process of implanting a stimulation electrode.

To provide a botulinum toxin for treating neuropsychiatric disorders and / or neurological disorders.SOLUTION: Provided is a botulinum toxin for use in the treatment of ASD (autism) in a patient in need thereof. Said treatment comprises administration of botulinum toxin to said patient by subcutaneous / intradermal injection. Administration to adults comprises injecting 2-4 units into and / or around the trigeminal nerve, 2-4 units into and / or around the cervical nerve outside the patient's spine, 2-4 units into and / or around the thoracic nerve outside the patient's spine, 2-4 units into and / or around the lumbar nerve outside the patient's spine, and / or 2-4 units into and / or around the sacral nerve outside the patient's spine. The total dosage of botulinum toxin for an adult human weighing about 150 pounds is no more than about 50 units, adjusted for age, weight, or a combination thereof.SELECTED DRAWING: None

The present disclosure relates to a closed-loop neuromodulation system based on sacral nerve electrophysiological activity monitoring. The closed-loop neuromodulation system includes an implantable neuromodulation module, a programming module, and a server module. The implantable neuromodulation module obtains monitoring data based on an implantable electrode and synchronously obtains a local field potential variation signal generated in a patient with urinary tract dysfunction during the sacral nerve conduction, and applies an electrical stimulation pulse to the sacral nerve of the patient when an abnormal monitoring result of nerve afferent impulses associated with urinary urgency symptom of the patient is obtained based on the local field potential variation signal. The server module stores the monitoring data and sends an intelligent recognition model that is pre-trained to the implantable neuromodulation module and the programming module, respectively.